1. Home
  2. DGHI vs ASMB Comparison

DGHI vs ASMB Comparison

Compare DGHI & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGHI
  • ASMB
  • Stock Information
  • Founded
  • DGHI 2017
  • ASMB 2005
  • Country
  • DGHI United States
  • ASMB United States
  • Employees
  • DGHI N/A
  • ASMB N/A
  • Industry
  • DGHI Finance: Consumer Services
  • ASMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • DGHI Finance
  • ASMB Health Care
  • Exchange
  • DGHI Nasdaq
  • ASMB Nasdaq
  • Market Cap
  • DGHI 90.1M
  • ASMB 92.1M
  • IPO Year
  • DGHI N/A
  • ASMB 2010
  • Fundamental
  • Price
  • DGHI $2.99
  • ASMB $13.42
  • Analyst Decision
  • DGHI Strong Buy
  • ASMB Buy
  • Analyst Count
  • DGHI 1
  • ASMB 2
  • Target Price
  • DGHI $2.50
  • ASMB $35.00
  • AVG Volume (30 Days)
  • DGHI 838.9K
  • ASMB 22.9K
  • Earning Date
  • DGHI 04-02-2025
  • ASMB 03-27-2025
  • Dividend Yield
  • DGHI N/A
  • ASMB N/A
  • EPS Growth
  • DGHI N/A
  • ASMB N/A
  • EPS
  • DGHI N/A
  • ASMB N/A
  • Revenue
  • DGHI $42,146,057.00
  • ASMB $28,326,000.00
  • Revenue This Year
  • DGHI N/A
  • ASMB $282.16
  • Revenue Next Year
  • DGHI N/A
  • ASMB N/A
  • P/E Ratio
  • DGHI N/A
  • ASMB N/A
  • Revenue Growth
  • DGHI 100.56
  • ASMB N/A
  • 52 Week Low
  • DGHI $0.84
  • ASMB $11.01
  • 52 Week High
  • DGHI $3.77
  • ASMB $19.93
  • Technical
  • Relative Strength Index (RSI)
  • DGHI 61.88
  • ASMB 40.25
  • Support Level
  • DGHI $2.81
  • ASMB $13.60
  • Resistance Level
  • DGHI $3.17
  • ASMB $14.25
  • Average True Range (ATR)
  • DGHI 0.49
  • ASMB 0.58
  • MACD
  • DGHI 0.02
  • ASMB -0.05
  • Stochastic Oscillator
  • DGHI 62.22
  • ASMB 5.93

About DGHI Digihost Technology Inc. Common Subordinate Voting Shares

Digihost Technology Inc is a blockchain company focused on Bitcoin mining. The company's mining facility is located in Buffalo, New York, and is equipped with an 18.7 MVA 115,000-kilovolt ampere outdoor substation with an option to increase the power output to 42MVA.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: